DEMOSTRACION DE INMUNIDAD FRENTE A TUMORES
ANTIGENOS TUMORALES
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
INMUNIDAD ANTITUMORAL
LINFOCITOS CD8+ Y CD4+
IL10
CANCER IMMUNOSURVEILLANCE
IKDC: DC PRODUCTORA DE IFN
NKT: DC RECONOCIMIENTO GLICOLIPIDOS
CANCER IMMUNOSURVEILLANCE
NK(NKGD2)
CANCER IMMUNOSURVEILLANCE
LT
CANCER IMMUNOSURVEILLANCE
ANTICUERPOS
CANCER IMMUNOSURVEILLANCE
CANCER IMMUNOSURVEILLANCE
NK, NKT, LT
HYPOTHETICAL LINK ENDOGENOUS SUPPRESION AND IMMUNOSURVEILLANCE
CANCER IMMUNOSURVEILLANCE
MECHANISMS OF TUMOR ESCAPE FROM THE IMMUNE SYSTEM
MIELOID SUPRESSOR CELLS
INDOLEAMINE 2,3DIOXYGENASE
MECHANISMS OF TUMOR ESCAPE FROM THE IMMUNE SYSTEM
CARACTERISTICAS CELULA TUMORAL
VIAS DE SEÑALIZACION CELULAR: FACTORES CRECIMIENTO vs. FACTORES ANTICRECIMIENTO
MICROAMBIENTE TUMORAL
LAS 3 “Es” DE INMUNOEDICION
VARIANTES CELULAS TUMORALES
CELULAS TUMORALES
CITOQUINAS
LAS 3 “Es” DE INMUNOEDICION
QUIMIOQUINASBloqueaANGIOGENESIS
FASE ELIMINACION
LAS 3 “Es” DE INMUNOEDICION
LAS 3 “Es” DE INMUNOEDICION
LAS 3 “Es” DE INMUNOEDICION
DENDRITIC-CELL DEFECTS
NORMAL DC DIFFERENTIATION
FUNCTIONAL CONSEQUENCES OF ABNORMAL DIFFERENTIATION IN CANCER
FUNCTIONAL CONSEQUENCES OF ABNORMAL DIFFERENTIATION IN CANCER
STAT3-MEDIATED SIGNALLING IN ABNORMAL DIFFERENTIATION OF DCs
FUNCTIONAL CONSEQUENCES OF ABNORMAL DIFFERENTIATION IN CANCER
NFkB-MEDIATED SIGNALLING IN ABNORMAL DIFFERENTIATION OF DCs
STAT3 IN THE TUMOR MICROENVIRONMENT
STAT3 CONSTITUTIVE ACTIVATION
STAT3 IN THE TUMOR MICROENVIRONMENT
STAT3 IN THE TUMOR MICROENVIRONMENT
HEMATOPOIETIC PROGENITOR CELLS
STAT3 IN THE TUMOR MICROENVIRONMENT
STAT3 IN THE TUMOR MICROENVIRONMENT
TARGETING STAT3 FOR CANCER IMMUNOTHERAPY
INHIBITORY B7-FAMILY MOLECULES IN THE TUMOUR MICROENVIRONMENT
INHIBITORY B7-FAMILY MOLECULES IN THE TUMOUR MICROENVIRONMENT
INHIBITORY B7-FAMILY MOLECULES IN THE TUMOUR MICROENVIRONMENT
INHIBITORY B7-FAMILY MOLECULES IN THE TUMOUR MICROENVIRONMENT
INHIBITORY B7-FAMILY MOLECULES IN THE TUMOUR MICROENVIRONMENT
SUPPRESSIVE MECHANISM OF TUMOUR ENVIRONMENTAL REGULATORY T CELL
NFkB SIGNALLING PATHWAYS
NFkB SIGNALLING PATHWAYS LINKING INFLAMMATION AND IMMUNITY TO CANCER DEVELOPMENT AND PROGRESSION
NFkB SIGNALLING PATHWAYS LINKING INFLAMMATION AND IMMUNITY TO CANCER DEVELOPMENT AND PROGRESSION
NFkB TUMOUR PROMOTING FUNCTIONS
NFkB SIGNALLING PATHWAYS LINKING INFLAMMATION AND IMMUNITY TO CANCER DEVELOPMENT AND PROGRESSION
CANCER CELL NECROSIS IS AN IMPORTANT DRIVER OF TUMOUR PROGRESSION
…”not enough of a good thing” PARADIGM
NATURAL AND ADAPTIVE Tregs
…”too much of a bad thing” PARADIGM
Recommended